Exact Mass: 805.3395

Exact Mass Matches: 805.3395

Found 28 metabolites which its exact mass value is equals to given mass value 805.3395, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Volixibat

{[4-(benzyloxy)-6-[({3-[3-butyl-7-(dimethylamino)-3-ethyl-4-hydroxy-1,1-dioxo-2,3,4,5-tetrahydro-1-benzothiepin-5-yl]phenyl}-C-hydroxycarbonimidoyl)amino]-3,5-dihydroxyoxan-2-yl]methoxy}sulphonic acid

C38H51N3O12S2 (805.2914)


   
   
   

(E)-2alpha,5alpha,8alpha-triacetoxy-3beta-benzoyloxy-15beta-hydroxy-7beta-isobutanoyloxy-9alpha-nicotinoyloxyjatropha-6(17),11-dien-14-one

(E)-2alpha,5alpha,8alpha-triacetoxy-3beta-benzoyloxy-15beta-hydroxy-7beta-isobutanoyloxy-9alpha-nicotinoyloxyjatropha-6(17),11-dien-14-one

C43H51NO14 (805.3309)


   

Volixibat

Volixibat

C38H51N3O12S2 (805.2914)


C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor C26170 - Protective Agent > C2081 - Hepatoprotective Agent D057847 - Lipid Regulating Agents

   
   
   

N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamide

N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamide

C46H51N3O10 (805.3574)


   

[6-[[3-[3-butyl-7-(dimethylamino)-3-ethyl-4-hydroxy-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-5-yl]phenyl]carbamoylamino]-3,5-dihydroxy-4-phenylmethoxyoxan-2-yl]methyl hydrogen sulfate

[6-[[3-[3-butyl-7-(dimethylamino)-3-ethyl-4-hydroxy-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-5-yl]phenyl]carbamoylamino]-3,5-dihydroxy-4-phenylmethoxyoxan-2-yl]methyl hydrogen sulfate

C38H51N3O12S2 (805.2914)


   

Conoideocrellide D

Conoideocrellide D

C41H51N5O12 (805.3534)


A natural product found in Conoideocrella tenuis.

   

6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranose

6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranose

C32H55NO22 (805.3216)


   

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-[6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->2)]-6-deoxy-alpha-L-mannopyranose

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-[6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->2)]-6-deoxy-alpha-L-mannopyranose

C32H55NO22 (805.3216)


   

[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-15-[(2R,3S)-3-(5,5-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-hydroxy-3-phenylpropanoyl]oxy-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-15-[(2R,3S)-3-(5,5-dimethyl-2-oxo-1,3-oxazolidin-3-yl)-2-hydroxy-3-phenylpropanoyl]oxy-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

C43H51NO14 (805.3309)


   
   

RS 09 (TFA)

RS 09 (TFA)

C33H50F3N9O11 (805.3582)


RS 09 TFA is a TLR4 agonist. RS 09 TFA promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages in vitro. RS 09 TFA acts as an adjuvant in vivo; RS 09 TFA enhances X-15 specific antibody serum concentrations, when administered with X-15-KLH in mice.

   

2,4,7-tris(acetyloxy)-3-(benzoyloxy)-13a-hydroxy-2,9,9,12-tetramethyl-5-methylidene-6-[(2-methylpropanoyl)oxy]-13-oxo-1h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

2,4,7-tris(acetyloxy)-3-(benzoyloxy)-13a-hydroxy-2,9,9,12-tetramethyl-5-methylidene-6-[(2-methylpropanoyl)oxy]-13-oxo-1h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

C43H51NO14 (805.3309)


   

(2s)-1-[(2s)-2-[(2s)-2-{[(2s)-2-{[(3r)-3-amino-10,10-dichloro-1-hydroxydecylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-n,4-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

(2s)-1-[(2s)-2-[(2s)-2-{[(2s)-2-{[(3r)-3-amino-10,10-dichloro-1-hydroxydecylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-n,4-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C40H57Cl2N5O8 (805.3584)


   

10-deacetyltaxuyunnanine a

NA

C44H55NO13 (805.3673)


{"Ingredient_id": "HBIN000091","Ingredient_name": "10-deacetyltaxuyunnanine a","Alias": "NA","Ingredient_formula": "C44H55NO13","Ingredient_Smile": "CCCCCC(=O)NC(C1=CC=CC=C1)C(C(=O)OC2CC3(C(C4C(C(CC5C4(CO5)OC(=O)C)O)(C(=O)C(C(=C2C)C3(C)C)O)C)OC(=O)C6=CC=CC=C6)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4786","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

10-deactyltaxuyunnanine a

NA

C44H55NO13 (805.3673)


{"Ingredient_id": "HBIN000097","Ingredient_name": "10-deactyltaxuyunnanine a","Alias": "NA","Ingredient_formula": "C44H55NO13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30475","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-epi-10-deacetyltaxuyunnanine a

NA

C44H55NO13 (805.3673)


{"Ingredient_id": "HBIN013167","Ingredient_name": "7-epi-10-deacetyltaxuyunnanine a","Alias": "NA","Ingredient_formula": "C44H55NO13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6883","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s)-1-[(2s)-2-[(2s,3s)-2-{[(2s)-2-{[(3r)-3-amino-10,10-dichloro-1-hydroxydecylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

(2s)-1-[(2s)-2-[(2s,3s)-2-{[(2s)-2-{[(3r)-3-amino-10,10-dichloro-1-hydroxydecylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C40H57Cl2N5O8 (805.3584)


   

(2s)-2-({[(1s)-1-{[(1s,2s)-2-[(2s)-2-amino-3-(4-hydroxyphenyl)-n-methylpropanamido]-1-({[(2r,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

(2s)-2-({[(1s)-1-{[(1s,2s)-2-[(2s)-2-amino-3-(4-hydroxyphenyl)-n-methylpropanamido]-1-({[(2r,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

C38H47N9O11 (805.3395)


   

14-[1,2-dihydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-3,6,9,12,15,18,21,22-octahydroxy-5-{[(1-hydroxy-3-methylbutylidene)amino]methyl}-17-(1-hydroxyethyl)-8-(hydroxymethyl)-11-isopropyl-1,4,7,10,13,16,19-heptaazacyclodocosa-1(22),3,6,9,12,15,18-heptaene-2-carboxylic acid

14-[1,2-dihydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-3,6,9,12,15,18,21,22-octahydroxy-5-{[(1-hydroxy-3-methylbutylidene)amino]methyl}-17-(1-hydroxyethyl)-8-(hydroxymethyl)-11-isopropyl-1,4,7,10,13,16,19-heptaazacyclodocosa-1(22),3,6,9,12,15,18-heptaene-2-carboxylic acid

C31H51N9O16 (805.3454)


   

n-[(1s,2r)-3-{[(1s,2s,3r,4s,7r,9s,10s,12r,15s)-4-(acetyloxy)-2-(benzoyloxy)-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-15-yl]oxy}-2-hydroxy-3-oxo-1-phenylpropyl]hexanimidic acid

n-[(1s,2r)-3-{[(1s,2s,3r,4s,7r,9s,10s,12r,15s)-4-(acetyloxy)-2-(benzoyloxy)-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-15-yl]oxy}-2-hydroxy-3-oxo-1-phenylpropyl]hexanimidic acid

C44H55NO13 (805.3673)


   

1-{2-[2-({2-[(3-amino-10,10-dichloro-1-hydroxydecylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-n,4-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoyl}pyrrolidine-2-carboxylic acid

1-{2-[2-({2-[(3-amino-10,10-dichloro-1-hydroxydecylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-n,4-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoyl}pyrrolidine-2-carboxylic acid

C40H57Cl2N5O8 (805.3584)


   

2-{[2-({2-[(1,2-dihydroxy-3-phenylpropylidene)amino]-1-hydroxypropylidene}amino)-1-hydroxyethylidene]amino}-n-{2-hydroxy-1-[(3-{4-[(4-hydroxy-3-methylbut-2-en-1-yl)oxy]phenyl}-1-methoxy-1-oxopropan-2-yl)-c-hydroxycarbonimidoyl]ethyl}-3-(4-hydroxyphenyl)propanimidic acid

2-{[2-({2-[(1,2-dihydroxy-3-phenylpropylidene)amino]-1-hydroxypropylidene}amino)-1-hydroxyethylidene]amino}-n-{2-hydroxy-1-[(3-{4-[(4-hydroxy-3-methylbut-2-en-1-yl)oxy]phenyl}-1-methoxy-1-oxopropan-2-yl)-c-hydroxycarbonimidoyl]ethyl}-3-(4-hydroxyphenyl)propanimidic acid

C41H51N5O12 (805.3534)


   

(2r)-2-{[(2r)-2-[(2-{[(2s)-2-{[(2s)-1,2-dihydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-hydroxy-n-[(2r)-3-(4-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]oxy}phenyl)-1-methoxy-1-oxopropan-2-yl]propanimidic acid

(2r)-2-{[(2r)-2-[(2-{[(2s)-2-{[(2s)-1,2-dihydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-hydroxy-n-[(2r)-3-(4-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]oxy}phenyl)-1-methoxy-1-oxopropan-2-yl]propanimidic acid

C41H51N5O12 (805.3534)


   

(2r,3r,3as,4r,6s,7s,8s,12s,13ar)-2,4,7-tris(acetyloxy)-3-(benzoyloxy)-13a-hydroxy-2,9,9,12-tetramethyl-5-methylidene-6-[(2-methylpropanoyl)oxy]-13-oxo-1h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

(2r,3r,3as,4r,6s,7s,8s,12s,13ar)-2,4,7-tris(acetyloxy)-3-(benzoyloxy)-13a-hydroxy-2,9,9,12-tetramethyl-5-methylidene-6-[(2-methylpropanoyl)oxy]-13-oxo-1h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

C43H51NO14 (805.3309)